NCT01537185View on ClinicalTrials.gov

Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

April 30, 2013

Conditions
Pneumococcal Vaccines
Interventions
OTHER

Placebo

3 cohorts of normal saline injection

BIOLOGICAL

SPWCV+Alum 100 mcg

3 injections 28 days apart

BIOLOGICAL

SPWCV+Alum 600 mcg

3 injections 28 days apart

BIOLOGICAL

SPWCV+Alum 300 mcg

3 injections 28 days apart

Trial Locations (1)

98418

Comprehensive Clinical Development, Tacoma

All Listed Sponsors
lead

PATH Vaccine Solutions

OTHER

NCT01537185 - Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults | Biotech Hunter | Biotech Hunter